effects [qlco]
Hormone replacement therapy [topp]
haemostatic [ortf]
variables [qlco]
Women [popg]
Verified [ftcn]
coronary artery disease [dsyn]
Estrogen [horm, phsu, strd]
Women [popg]
Atherosclerosis [dsyn]
Study [mnob]
Hormone replacement therapy [topp]
Haemostasis [ortf]
Inconsistent [qlco]
Few [qnco]
Women [popg]
coronary artery disease [dsyn]
Single [popg]
Center [spco]
Open [spco]
randomized [resa]
Study [mnob]
postmenopausal [tmco]
Women [popg]
Verified [ftcn]
coronary artery disease [dsyn]
randomized [resa]
Hormone replacement therapy [topp]
GIVEN [cnce]
Long [qlco]
Cycle [tmco]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
mU/g [qnco]
Hour [tmco]
3 Months [tmco]
Sequential [idcn]
medroxyprogesterone acetate [horm, phsu, strd]
days [tmco]
Control Group [grup]
Receive [qlco]
therapy [ftcn]
haemostatic [ortf]
Parameters [fndg]
Measured [qlco]
baseline [bodm]
months [tmco]
therapy [ftcn]
Coagulation [ortf]
inhibitors [chvf]
Antithrombin [aapp, phsu]
Protein C [aapp, bacs, phsu]
Protein S [aapp, bacs]
Tissue factor pathway inhibitor [aapp, phsu]
Decreased [qnco]
baseline [bodm]
Hormone replacement therapy [topp]
Group [idcn]
months [tmco]
Compared [acty]
Control Group [grup]
Absolute [qlco]
decreases [qnco]
Hormone replacement therapy [topp]
Group [idcn]
treatment [ftcn]
Group [idcn]
Observed [ftcn]
Coagulation [ortf]
Products [enty]
Prothrombin fragment 1+2 [aapp, bacs]
Thrombin-antithrombin complex [aapp, enzy]
D-dimer [aapp, bacs]
decreases [qnco]
Levels [qlco]
Hormone replacement therapy [topp]
Group [idcn]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
Factor VII, Activated [aapp, enzy, phsu]
Factor VII [aapp, bacs, phsu]
Antigen [imft]
Hormone replacement therapy [topp]
treatment [ftcn]
Detected [fndg]
fibrinolytic [topp]
Parameters [fndg]
Tissue Plasminogen Activator [aapp, enzy, phsu]
activity [dora]
Tissue Plasminogen Activator Antigen [imft]
Global [spco]
fibrinolytic [topp]
activity [dora]
Plasminogen Activator Inhibitor Type 1 [aapp, bacs]
Hormone replacement therapy [topp]
Group [idcn]
Questionable [qlco]
Levels [qlco]
Control Group [grup]
treatment [ftcn]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Combined [qlco]
Long [qlco]
Cycle [tmco]
Progestins [horm, phsu, strd]
Reticular [spco]
Activation [acty]
Coagulation [ortf]
Reduced [qlco]
Levels [qlco]
Coagulation [ortf]
inhibitors [chvf]
Science [ocdi]
LTD [ortf]
Reserve [acty]
